Sam Chun Dang Pharm Appoints Former Financial Supervisory Service Official Jo Cheol-rae as Outside Director, Boosting Board Independence

Sam Chun Dang Pharm appointed Jo Cheol-rae, a former team leader, deputy director, and director at the Financial Supervisory Service and currently an advisor at Samsung Global Research, as a new outside director effective June 30, 2026.
The appointment increases the total number of registered directors from four to five and outside directors from one to two, raising the outside director ratio from 25% to 40%.
The addition of a regulatory expert is expected to strengthen board independence and internal control capabilities.
[AI Summary]This outside director appointment is a governance-focused move with no capital or financial impact; the recruitment of a regulatory expert enhances long-term risk management and may positively influence investor sentiment.